{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:14:15Z","timestamp":1793830455314,"version":"4.6.1"},"reference-count":188,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["19OK007"],"award-info":[{"award-number":["19OK007"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["21OSR007"],"award-info":[{"award-number":["21OSR007"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.autrev.2022.103211","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T14:20:42Z","timestamp":1665757242000},"page":"103211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue"],"prefix":"10.1016","volume":"21","author":[{"given":"Lianne E.","family":"Kwant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosta","family":"Vegting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel W.P.","family":"Tsang-a-Sjoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan J.","family":"Kwakernaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liffert","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre E.","family":"Voskuyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald F.","family":"van Vollenhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno P.J.","family":"de Winther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederike J.","family":"Bemelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Anders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc L.","family":"Hilhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103211_bb0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.semarthrit.2008.10.007","article-title":"Understanding the epidemiology and progression of systemic lupus erythematosus","volume":"39","author":"Pons-Estel","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103211_bb0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update \u03bfn the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103211_bb0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103211_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2022.103211_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.reuma.2010.11.001","article-title":"Multiethnic lupus cohorts: what have they taught us?","author":"Alarc\u00f3n","year":"2011","journal-title":"Reumatol Clin, Spain"},{"key":"10.1016\/j.autrev.2022.103211_bb0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1574887112666171123113200","article-title":"Lupus nephritis: current treatment paradigm and unmet needs","volume":"13","author":"Menez","year":"2018","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.autrev.2022.103211_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41581-021-00510-7","article-title":"Nephron overload as a therapeutic target to maximize kidney lifespan","volume":"18","author":"Luyckx","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0040","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2022.103211_bb0050","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of patients with lupus nephritis","volume":"20","author":"Arazi","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12865-019-0316-x","article-title":"Immune cell infiltration characteristics and related core genes in lupus nephritis: results from bioinformatic analysis","volume":"20","author":"Cao","year":"2019","journal-title":"BMC Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0060","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI200419139","article-title":"Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli","volume":"113","author":"Peterson","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2022.103211_bb0065","first-page":"43","article-title":"Therapeutic targeting of macrophages in lupus nephritis","volume":"20","author":"Chalmers","year":"2015","journal-title":"Discov Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0070","doi-asserted-by":"crossref","first-page":"13534","DOI":"10.1074\/jbc.M113.457218","article-title":"DNA-dependent activator of interferon-regulatory factors (DAI) promotes lupus nephritis by activating the calcium pathway","volume":"288","author":"Zhang","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2022.103211_bb0075","article-title":"Granulin exacerbates lupus nephritis via enhancing macrophage M2b polarization","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2022.103211_bb0080","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.4049\/jimmunol.1002315","article-title":"Macrophage differentiation and polarization via phosphatidylinositol 3-kinase\/Akt-ERK signaling pathway conferred by serum amyloid P component","volume":"187","author":"Zhang","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0085","article-title":"Mannose-binding lectin blunts macrophage polarization and ameliorates lupus nephritis","volume":"8","author":"Cai","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2022.103211_bb0090","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1159\/000430251","article-title":"Macrophage Polarization Modulates Development of Systemic Lupus Erythematosus","volume":"37","author":"Li","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.autrev.2022.103211_bb0095","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/ndt\/gfy195","article-title":"Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype","volume":"34","author":"Zhang","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103211_bb0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2019.01.004","article-title":"PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus","volume":"99","author":"Horuluoglu","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2022.103211_bb0105","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.prp.2017.04.011","article-title":"Significance of M2 macrophages in glomerulonephritis with crescents","volume":"213","author":"Li","year":"2017","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.autrev.2022.103211_bb0110","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ekir.2021.12.030","article-title":"Use of glomerular CD68+ cells as a surrogate marker for endocapillary hypercellularity in lupus nephritis","volume":"7","author":"Bos","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2022.103211_bb0115","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0272-6386(99)70418-X","article-title":"Intraglomerular monocyte infiltration and immune deposits in diffuse lupus glomerulonephritis","volume":"33","author":"Ichiryu","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2022.103211_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13075-016-0989-y","article-title":"CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis","volume":"18","author":"Olmes","year":"2016","journal-title":"Arthrit Res Ther"},{"key":"10.1016\/j.autrev.2022.103211_bb0125","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1523-1755.2001.00492.x","article-title":"Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages","volume":"59","author":"Hill","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103211_bb0130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13075-016-0989-y","article-title":"CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis","volume":"18","author":"Olmes","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2022.103211_bb0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40620-015-0252-7","article-title":"Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis","volume":"30","author":"Dias","year":"2017","journal-title":"J Nephrol"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2022.103211_bb0140","first-page":"S246","article-title":"Glomerular macrophage is an indicator of early treatment response in diffuse proliferative lupus nephritis","volume":"96","author":"Cheunsuchon","year":"2013","journal-title":"J Med Assoc Thail"},{"key":"10.1016\/j.autrev.2022.103211_bb0145","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4049\/jimmunol.180.3.1938","article-title":"Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis","volume":"180","author":"Schiffer","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0150","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1681\/ASN.V1271369","article-title":"Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis","volume":"12","author":"Lema","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0155","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.190.12.1813","article-title":"Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice","volume":"190","author":"Tesch","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0160","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1681\/ASN.2005040426","article-title":"Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL\/lpr lupus-prone mice","volume":"16","author":"P\u00e9rez de Lema","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0165","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1681\/ASN.2006121348","article-title":"Spiegelmer inhibition of CCL2\/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice","volume":"18","author":"Kulkarni","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0170","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1124\/jpet.108.142711","article-title":"Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice","volume":"328","author":"Kulkarni","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.autrev.2022.103211_bb0175","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/01.ASN.0000130082.67775.60","article-title":"Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice","volume":"15","author":"Anders","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2016.07.003","article-title":"Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis","volume":"169","author":"Devarapu","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.semnephrol.2006.09.010","article-title":"Chemokines and chemokine receptors as therapeutic targets in lupus nephritis","volume":"27","author":"Vielhauer","year":"2007","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0190","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.4049\/jimmunol.176.4.2095","article-title":"Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus","volume":"176","author":"Denny","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0195","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ki.2011.217","article-title":"Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis","volume":"80","author":"Anders","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103211_bb0200","first-page":"1596","article-title":"Structure and function of renal macrophages and dendritic cells from lupus-prone mice, Arthritis","volume":"66","author":"Sahu","year":"2014","journal-title":"Rheumatol"},{"key":"10.1016\/j.autrev.2022.103211_bb0205","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.4049\/jimmunol.1003010","article-title":"A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis","volume":"186","author":"Bethunaickan","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0210","first-page":"151","article-title":"Macrophage subpopulations in systemic lupus erythematosus","volume":"13","author":"Orme","year":"2012","journal-title":"Discov Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0215","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1182\/blood-2009-07-235028","article-title":"Comparison of gene expression profiles between human and mouse monocyte subsets","volume":"115","author":"Ingersoll","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2022.103211_bb0220","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3389\/fphys.2017.00837","article-title":"The origins and functions of tissue-resident macrophages in kidney development","volume":"8","author":"Munro","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.autrev.2022.103211_bb0225","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri3671","article-title":"Monocytes and macrophages: developmental pathways and tissue homeostasis","volume":"14","author":"Ginhoux","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","article-title":"Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis","volume":"38","author":"Yona","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2022.103211_bb0235","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1681\/ASN.2019040419","article-title":"The kidney contains ontogenetically distinct dendritic cell and macrophage subtypes throughout development that differ in their inflammatory properties","volume":"31","author":"Salei","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0240","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.immuni.2013.04.004","article-title":"Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes","volume":"38","author":"Hashimoto","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2022.103211_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/951390","article-title":"Tissues use resident dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon tissue injury: the immunoregulatory role of changing tissue environments","volume":"2012","author":"Lech","year":"2012","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.autrev.2022.103211_bb0250","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.4049\/jimmunol.0901473","article-title":"Bone marrow Ly6C<sup>high<\/sup> monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations","volume":"183","author":"Lin","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0255","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3389\/fimmu.2019.01951","article-title":"Accelerated and severe lupus nephritis benefits from m1, an active metabolite of ginsenoside, by regulating NLRP3 inflammasome and T cell functions in mice","volume":"10","author":"Lin","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0260","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0265","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.4049\/jimmunol.141.9.3050","article-title":"Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis","volume":"141","author":"Boswell","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0270","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0961203308094764","article-title":"Up-regulated renal expression of TNF-alpha signalling adapter proteins in lupus glomerulonephritis","volume":"18","author":"Zhu","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103211_bb0275","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/ard.2004.033753","article-title":"Type I interferon correlates with serological and clinical manifestations of SLE","volume":"64","author":"Dall\u2019era","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103211_bb0280","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/eji.200526327","article-title":"C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist","volume":"35","author":"Bao","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0285","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1523-1755.2001.00780.x","article-title":"Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization","volume":"60","author":"Abe","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103211_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103134","article-title":"New insights for regulatory T cell in lupus nephritis","volume":"21","author":"Li","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103211_bb0295","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1002\/art.34553","article-title":"Anti-tumor necrosis factor \u03b1 treatment of interferon-\u03b1-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation","volume":"64","author":"Bethunaickan","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103211_bb0300","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1172\/JCI97650","article-title":"iRhom2 promotes lupus nephritis through TNF-\u03b1 and EGFR signaling","volume":"128","author":"Qing","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2022.103211_bb0305","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41467-018-04717-4","article-title":"C-terminal truncation of IFN-\u03b3 inhibits proinflammatory macrophage responses and is deficient in autoimmune disease","volume":"9","author":"Dufour","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2022.103211_bb0310","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.4049\/jimmunol.1102154","article-title":"Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice","volume":"188","author":"Iwata","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0315","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1681\/ASN.2021060815","article-title":"Intensity of macrophage infiltration in glomeruli predicts response to immunosuppressive therapy in patients with IgA nephropathy","volume":"32","author":"Xie","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0320","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4049\/jimmunol.1002230","article-title":"Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency","volume":"186","author":"Roszer","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0325","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1177\/0961203318804922","article-title":"Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis","volume":"27","author":"Barbado","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103211_bb0330","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1681\/ASN.2021091239","article-title":"IgA nephropathy needs a diagnostic marker of immunologic activity to select the right patients for immunotherapies","volume":"32","author":"Hilhorst","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0335","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/ndt\/gfw214","article-title":"Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis","volume":"31","author":"Endo","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103211_bb0340","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1681\/ASN.2019121285","article-title":"Urinary soluble CD163: a novel noninvasive biomarker of activity for lupus nephritis","volume":"31","author":"Mejia-Vilet","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0345","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3389\/fimmu.2020.00671","article-title":"Association of urine sCD163 with proliferative lupus nephritis, fibrinoid necrosis, cellular crescents and intrarenal M2 macrophages","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0350","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13075-018-1568-1","article-title":"Dysregulated heme oxygenase-1(low) M2-like macrophages augment lupus nephritis via Bach1 induced by type I interferons","volume":"20","author":"Kishimoto","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2022.103211_bb0355","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/JLB.3RU1018-378RR","article-title":"M2b macrophage polarization and its roles in diseases","volume":"106","author":"Wang","year":"2019","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2022.103211_bb0360","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.4049\/jimmunol.1601565","article-title":"Dependence of glomerulonephritis induction on novel intraglomerular alternatively activated bone marrow-derived macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice","volume":"198","author":"Sung","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0365","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MNH.0000000000000186","article-title":"Monocyte chemoattractant protein-1 and the kidney","volume":"25","author":"Haller","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.autrev.2022.103211_bb0370","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000335733","article-title":"Regulation of macrophage and dendritic cell responses by their lineage precursors","volume":"4","author":"Cortez-Retamozo","year":"2012","journal-title":"J Innate Immun"},{"key":"10.1016\/j.autrev.2022.103211_bb0375","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1007\/s10067-017-3787-2","article-title":"Upregulation of CD16- monocyte subsets in systemic lupus erythematous patients","volume":"36","author":"Wu","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103211_bb0380","first-page":"9324315","article-title":"Infiltrating CD16(+) are associated with a reduction in peripheral CD14(+)CD16(++) monocytes and severe forms of lupus nephritis","volume":"2016","author":"Barrera Garc\u00eda","year":"2016","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.autrev.2022.103211_bb0385","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","article-title":"Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors","volume":"33","author":"Cros","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2022.103211_bb0390","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1126\/science.1142883","article-title":"Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior","volume":"317","author":"Auffray","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.autrev.2022.103211_bb0395","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.ajkd.2007.04.012","article-title":"Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis","volume":"50","author":"Yoshimoto","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2022.103211_bb0400","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96492","article-title":"Intracapillary immune complexes recruit and activate slan-expressing CD16+ monocytes in human lupus nephritis","volume":"3","author":"Olaru","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2022.103211_bb0405","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1172\/JCI125116","article-title":"Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis","volume":"129","author":"Kuriakose","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2022.103211_bb0410","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1046\/j.1523-1755.1999.00431.x","article-title":"Detection of urinary macrophages expressing the CD16 (Fc gamma RIII) molecule: a novel marker of acute inflammatory glomerular injury","volume":"55","author":"Hotta","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103211_bb0415","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s11255-017-1781-x","article-title":"Novel acute kidney injury biomarkers: their characteristics, utility and concerns","volume":"50","author":"Beker","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0420","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.ajpath.2017.07.020","article-title":"Systemic monocyte chemotactic Protein-1 inhibition modifies renal macrophages and restores glomerular endothelial glycocalyx and barrier function in diabetic nephropathy","volume":"187","author":"Boels","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2022.103211_bb0425","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J Interf Cytokine Res"},{"key":"10.1016\/j.autrev.2022.103211_bb0430","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cellsig.2018.02.006","article-title":"Identification of macrophage-related candidate genes in lupus nephritis using bioinformatics analysis","volume":"46","author":"Shu","year":"2018","journal-title":"Cell Signal"},{"key":"10.1016\/j.autrev.2022.103211_bb0435","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1681\/ASN.V1271369","article-title":"Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis","volume":"12","author":"P\u00e9rez de Lema","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0440","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1073\/pnas.91.7.2752","article-title":"Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails","volume":"91","author":"Charo","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2022.103211_bb0445","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20022156","article-title":"Fractalkine preferentially mediates arrest and migration of CD16+ monocytes","volume":"197","author":"Ancuta","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0450","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00393-008-0283-8","article-title":"CCL2\/MCP1: a novel target in systemic lupus erythematosus and lupus nephritis","volume":"67","author":"Kulkarni","year":"2008","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.autrev.2022.103211_bb0455","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI29919","article-title":"Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites","volume":"117","author":"Tsou","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2022.103211_bb0460","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010343","article-title":"Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: a case-control study","volume":"97","author":"Dong","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103211_bb0465","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s10067-016-3404-9","article-title":"Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity","volume":"35","author":"Gupta","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103211_bb0470","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1523-1755.1999.00646.x","article-title":"MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis","volume":"56","author":"Wada","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103211_bb0475","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/eji.201646387","article-title":"Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4(+) and CD8(+) T cells and macrophages","volume":"47","author":"Klocke","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0480","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s10875-011-9555-1","article-title":"Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis","volume":"31","author":"El-Shehaby","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0485","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0961203320914372","article-title":"Diagnostic value of urinary monocyte chemoattractant protein-1 in evaluating the activity of lupus nephritis: a meta-analysis","volume":"29","author":"Xia","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103211_bb0490","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/art.20266","article-title":"Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis","volume":"50","author":"Tucci","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103211_bb0495","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ki.1996.105","article-title":"Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis","volume":"49","author":"Wada","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103211_bb0500","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1196\/annals.1361.084","article-title":"The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis","volume":"1051","author":"Tucci","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2022.103211_bb0505","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1681\/ASN.2011010038","article-title":"Distinct roles of CSF-1 isoforms in lupus nephritis","volume":"22","author":"Menke","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0510","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1681\/ASN.2009050499","article-title":"Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis","volume":"20","author":"Menke","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0515","first-page":"403","article-title":"Glomerular expression of macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in patients with various forms of glomerulonephritis","volume":"75","author":"Matsuda","year":"1996","journal-title":"Lab Investig"},{"key":"10.1016\/j.autrev.2022.103211_bb0520","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1681\/ASN.2013121356","article-title":"Colony-stimulating factor-1: a potential biomarker for lupus nephritis","volume":"26","author":"Menke","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0525","first-page":"255","article-title":"Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice","volume":"139","author":"Yui","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2022.103211_bb0530","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/ard.2007.076117","article-title":"Increase in the level of macrophage colony-stimulating factor in patients with systemic lupus erythematosus","volume":"67","author":"Yang","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103211_bb0535","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/385640a0","article-title":"A new class of membrane-bound chemokine with a CX3C motif","volume":"385","author":"Bazan","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2022.103211_bb0540","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.4049\/jimmunol.164.6.3368","article-title":"Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa","volume":"164","author":"Muehlhoefer","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0545","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2022.103211_bb0550","doi-asserted-by":"crossref","first-page":"F207","DOI":"10.1152\/ajprenal.00482.2009","article-title":"Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models","volume":"299","author":"Nakatani","year":"2010","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.autrev.2022.103211_bb0555","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.21007","article-title":"Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL\/lpr mice","volume":"52","author":"Inoue","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103211_bb0560","first-page":"915","article-title":"Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin)","volume":"144","author":"Pichler","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2022.103211_bb0565","first-page":"50","article-title":"A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat","volume":"110","author":"Yu","year":"1998","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1016\/j.autrev.2022.103211_bb0570","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.271.5248.509","article-title":"Receptor-ligand interaction between CD44 and osteopontin (Eta-1)","volume":"271","author":"Weber","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.autrev.2022.103211_bb0575","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1053\/ajkd.2000.9790","article-title":"Tubular osteopontin expression in human glomerulonephritis and renal vasculitis","volume":"36","author":"Okada","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2022.103211_bb0580","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/08916939808996282","article-title":"Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis","volume":"28","author":"W\u00fcthrich","year":"1998","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2022.103211_bb0585","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.194.6.781","article-title":"C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells","volume":"194","author":"Ogden","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0590","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0171-2985(98)80032-6","article-title":"C1q and systemic lupus erythematosus","volume":"199","author":"Walport","year":"1998","journal-title":"Immunobiology"},{"key":"10.1016\/j.autrev.2022.103211_bb0595","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/TP.0000000000000975","article-title":"Allogeneic hematopoietic stem cell transplantation in the treatment of human C1q deficiency: the karolinska experience","volume":"100","author":"Olsson","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.autrev.2022.103211_bb0600","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaci.2013.07.035","article-title":"Successful cure of C1q deficiency in human subjects treated with hematopoietic stem cell transplantation","volume":"133","author":"Arkwright","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0605","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1093\/ndt\/gfl436","article-title":"High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis","volume":"21","author":"Trendelenburg","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103211_bb0610","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/ard.2004.024943","article-title":"Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus","volume":"64","author":"Marto","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103211_bb0615","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1189\/jlb.3A1215-535R","article-title":"Anti-C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophages","volume":"101","author":"Thanei","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2022.103211_bb0620","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.4049\/jimmunol.1501659","article-title":"Anti-C1q autoantibodies from systemic lupus erythematosus patients induce a proinflammatory phenotype in macrophages","volume":"196","author":"Thanei","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0625","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molimm.2008.09.026","article-title":"Complement Receptor 1: disease associations and therapeutic implications","volume":"46","author":"Khera","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0630","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41577-019-0167-y","article-title":"How macrophages deal with death","volume":"19","author":"Lemke","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0635","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/oxfordjournals.ndt.a091565","article-title":"Abnormal podocyte CR-1 expression in glomerular diseases: association with glomerular cell proliferation and monocyte infiltration","volume":"2","author":"Nolasco","year":"1987","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103211_bb0640","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semarthrit.2018.11.005","article-title":"Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: case series and review of literature","volume":"49","author":"Kello","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103211_bb0645","first-page":"2286","article-title":"Eculizumab as rescue therapy in severe resistant lupus nephritis","volume":"54","author":"Pickering","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103211_bb0650","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/ar2590","article-title":"Increased expression of FcgammaRI\/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus","volume":"11","author":"Li","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2022.103211_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103016","article-title":"Fc receptors gone wrong: a comprehensive review of their roles in autoimmune and inflammatory diseases","volume":"21","author":"Chalayer","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103211_bb0660","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/0003-4819-97-4-526","article-title":"Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis","volume":"97","author":"Parris","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0665","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/rheumatology\/kev433","article-title":"Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis","volume":"55","author":"Tsang","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103211_bb0670","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12916-016-0673-8","article-title":"Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis","volume":"14","author":"Singh","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0675","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/annrheumdis-2016-210960","article-title":"European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative","volume":"76","author":"Groot","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103211_bb0680","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1574884713666180403150359","article-title":"Lupus nephritis: a treatment update","volume":"13","author":"Aziz","year":"2018","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.autrev.2022.103211_bb0685","first-page":"199","article-title":"Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis","volume":"70","author":"van Tellingen","year":"2012","journal-title":"Neth J Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102898","article-title":"Eurolupus cyclophosphamide plus repeated pulses of methyl-prednisolone for the induction therapy of class III IV and V lupus nephritis","volume":"20","author":"Ruiz-Irastorza","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103211_bb0695","doi-asserted-by":"crossref","first-page":"vi21","DOI":"10.1093\/rheumatology\/keab498","article-title":"New developments in systemic lupus erythematosus","volume":"60","author":"Tsang","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103211_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102911","article-title":"Monocytes and macrophages in ANCA-associated vasculitis","volume":"20","author":"Vegting","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103211_bb0705","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1681\/ASN.2021060815","article-title":"Intensity of macrophage infiltration in glomeruli predicts response to immunosuppressive therapy in patients with IgA nephropathy","volume":"32","author":"Xie","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103211_bb0710","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3389\/fimmu.2018.01948","article-title":"Microthrombotic renal vascular lesions are associated to increased renal inflammatory infiltration in murine lupus nephritis","volume":"9","author":"Gonzalo-Gil","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0715","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ndt\/gfv459","article-title":"C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria","volume":"32","author":"Menne","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103211_bb0720","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.4049\/jimmunol.0801920","article-title":"CXCR4\/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus","volume":"182","author":"Wang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0725","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.4049\/jimmunol.170.6.3254","article-title":"Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation","volume":"170","author":"Lenda","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0730","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.11.007","article-title":"Macrophage depletion ameliorates nephritis induced by pathogenic antibodies","volume":"57","author":"Chalmers","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2022.103211_bb0735","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar2341","article-title":"The role of tumor necrosis factor-alpha in systemic lupus erythematosus","volume":"10","author":"Aringer","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2022.103211_bb0740","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/art.20576","article-title":"Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study","volume":"50","author":"Aringer","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103211_bb0745","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s10067-010-1484-5","article-title":"Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis","volume":"29","author":"Tanaka","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103211_bb0750","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJMoa1610528","article-title":"Overexpression of the cytokine BAFF and autoimmunity risk","volume":"376","author":"Steri","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0755","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0760","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1073\/pnas.97.7.3370","article-title":"Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice","volume":"97","author":"Khare","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2022.103211_bb0765","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V97.1.198","article-title":"Synthesis and release of B-lymphocyte stimulator from myeloid cells","volume":"97","author":"Nardelli","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2022.103211_bb0770","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1182\/blood-2002-10-3123","article-title":"Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF","volume":"101","author":"Craxton","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2022.103211_bb0775","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1126\/science.285.5425.260","article-title":"BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator","volume":"285","author":"Moore","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.autrev.2022.103211_bb0780","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood-2005-12-017319","article-title":"A role for BLyS in the activation of innate immune cells","volume":"108","author":"Chang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2022.103211_bb0785","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/89790","article-title":"Activation and accumulation of B cells in TACI-deficient mice","volume":"2","author":"Yan","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0790","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0795","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02698","article-title":"Inhibition of membrane-bound BAFF by the anti-BAFF antibody belimumab","volume":"9","author":"Kowalczyk-Quintas","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0800","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncprheum0424","article-title":"Drug insight: the mechanism of action of rituximab in autoimmune disease--the immune complex decoy hypothesis","volume":"3","author":"Taylor","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2022.103211_bb0805","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ncprheum0042","article-title":"B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus","volume":"2","author":"Eisenberg","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2022.103211_bb0810","first-page":"538","article-title":"B-cell compartment as the selective target for the treatment of immune thrombocytopenias","volume":"88","author":"Zaja","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.autrev.2022.103211_bb0815","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/rheumatology\/kex067","article-title":"Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples","volume":"56","author":"Reddy","year":"2017","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.autrev.2022.103211_bb0820","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood.V122.21.5136.5136","article-title":"Obinutuzumab (GA101) more potently engages phagocytic-lineage cells resulting in enhanced monocyte and macrophage activity when compared to rituximab and ofatumumab","volume":"122","author":"Herter","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2022.103211_bb0825","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJMoa2023325","article-title":"Targeting CD38 with daratumumab in refractory systemic lupus erythematosus","volume":"383","author":"Ostendorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0830","article-title":"Monoclonal antibody Daratumumab promotes macrophage-mediated anti-myeloma phagocytic activity via engaging FC gamma receptor and activation of macrophages","volume":"12","author":"Gao","year":"2022","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.autrev.2022.103211_bb0835","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0840","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2022.103211_bb0845","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02824","article-title":"DNA-mediated interferon signature induction by SLE serum occurs in monocytes through two pathways: a mechanism to inhibit both pathways","volume":"9","author":"Porat","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0850","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.20050914","article-title":"Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus","volume":"202","author":"Barrat","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0855","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.autrev.2018.02.011","article-title":"The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trials","volume":"17","author":"Felten","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103211_bb0860","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000270","article-title":"Interferon pathway in SLE: one key to unlocking the mystery of the disease","volume":"6","author":"R\u00f6nnblom","year":"2019","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0865","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0870","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/annrheumdis-2021-221478","article-title":"Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis","volume":"81","author":"Jayne","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103211_bb0875","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/annrheumdis-2019-216379","article-title":"IFN-\u03b1 kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study","volume":"79","author":"Houssiau","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103211_bb0880","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/ar3895","article-title":"Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"14","author":"Sacre","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2022.103211_bb0885","article-title":"Hydroxychloroquine Inhibits macrophage activation and attenuates renal fibrosis after ischemia-reperfusion injury","volume":"12","author":"Zheng","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0890","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00007890-199908150-00014","article-title":"Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines","volume":"68","author":"Cohn","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.autrev.2022.103211_bb0895","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0008-8749(02)00502-6","article-title":"Mycophenolic acid inhibits inosine 5\u2032-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages","volume":"216","author":"Jonsson","year":"2002","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0900","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.lfs.2006.01.015","article-title":"Inhibition of inducible nitric oxide synthesis by azathioprine in a macrophage cell line","volume":"79","author":"Moeslinger","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.autrev.2022.103211_bb0905","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.autrev.2019.03.004","article-title":"Refractory lupus nephritis: when, why and how to treat","volume":"18","author":"Kronbichler","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103211_bb0910","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41467-019-10491-8","article-title":"Mesenchymal stem cell therapy induces FLT3L and CD1c(+) dendritic cells in systemic lupus erythematosus patients","volume":"10","author":"Yuan","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2022.103211_bb0915","first-page":"R1282","article-title":"Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus","volume":"296","author":"Venegas-Pont","year":"2009","journal-title":"Am J Phys Regul Integr Comp Phys"},{"key":"10.1016\/j.autrev.2022.103211_bb0920","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4049\/jimmunol.182.1.340","article-title":"The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin","volume":"182","author":"Aprahamian","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0925","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejim.2006.09.007","article-title":"Thiazolidinediones for the treatment of type 2 diabetes","volume":"18","author":"Elte","year":"2007","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2022.103211_bb0930","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0961203311422096","article-title":"Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial","volume":"21","author":"Juarez-Rojas","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103211_bb0935","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.4049\/jimmunol.1402004","article-title":"Effect of TLR agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells","volume":"194","author":"Wang","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103211_bb0940","first-page":"705","article-title":"Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production","volume":"32","author":"Li","year":"2014","journal-title":"Clin Exp Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:28:11Z","timestamp":1761600491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222001811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":188,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1568997222001811"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103211","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103211"}}